Recombinant Human TP53BP1 Protein，His

TP53BP1 (Tumor Protein p53 Binding Protein 1) is a critical protein involved in the cellular response to DNA damage and the maintenance of genomic stability, making it a significant focus in cancer research. This protein acts as a mediator in the pathway of DNA double-strand break repair, interacting with various components of the DNA damage response (DDR) machinery. Mutations or dysregulation of TP53BP1 have been associated with increased susceptibility to cancer and poor prognosis in affected individuals, particularly in cancers linked to genomic instability. Researchers have increasingly turned their attention to recombinant forms of TP53BP1 to better understand its structural and functional properties. By studying these recombinant proteins, scientists aim to elucidate the mechanisms underlying TP53BP1's role in DDR and its interactions with other proteins, such as p53, BRCA1, and RAD51. Furthermore, the development of recombinant TP53BP1 can facilitate investigations into therapeutic strategies that target DDR pathways, offering potential advancements in cancer treatment and personalized medicine. The intricate balance TP53BP1 maintains in regulating apoptosis and cell cycle checkpoints underscores its relevance in not only tumorigenesis but also in the broader context of cellular health. As research progresses, understanding the detailed functions of TP53BP1 through its recombinant forms may lead to innovative approaches in combating various malignancies and enhancing the efficacy of existing therapies. This ongoing study of TP53BP1 represents a promising frontier in both basic and translational cancer research, aiming to unveil new insights that could pave the way for novel diagnostic and therapeutic options.